4.6 Review

Management of the multiple symptoms of irritable bowel syndrome

Journal

LANCET GASTROENTEROLOGY & HEPATOLOGY
Volume 2, Issue 2, Pages 112-122

Publisher

ELSEVIER INC
DOI: 10.1016/S2468-1253(16)30116-9

Keywords

-

Funding

  1. Faculty of Medicine, University of Gothenburg, Sweden
  2. AFA Insurance
  3. Swedish Medical Research Council [13409, 21692, 21691]
  4. Ferring Pharmaceuticals
  5. US National Institute of Diabetes and Digestive and Kidney Diseases [RO1 DK31369]

Ask authors/readers for more resources

Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders. A stepwise management approach is advocated for patients with IBS. For a substantial proportion of patients with mild symptoms, general management principles, including making a confident diagnosis and offering explanation, reassurance, and dietary and lifestyle advice, are sufficient. However, many patients continue to have moderate-to-severe symptoms and are not satisfied solely with this approach. In these patients, use of pharmacotherapy on the basis of the predominant symptom (constipation, diarrhoea, pain, or bloating) or combination of symptoms is the next step. For patients with symptoms that are refractory to these initial treatment options and those who have comorbid conditions or psychological symptoms, a combination of therapies should be used, and the use of psychotropic drugs and psychological treatment alternatives is often effective. Finally, the key to successful treatment of patients with IBS is a good physician-patient relationship and use of person-centred care principles.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available